Supriya Lifesci.

Market Cap: Mid Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE07RO01027
NSEID: SUPRIYA
BSEID: 543434

INR

712.60

50.2 (7.58%)

BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 4.05 lacs

Click here to access the older version

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Rs cr

Standalone Quarterly Results

Dec'24

Sep'24

Jun'24

Mar'24

Dec'23

Sep'23

Jun'23

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Dec 2024 is 11.77% vs 3.41% in Sep 2024

Standalone Net Profit

QoQ Growth in quarter ended Dec 2024 is 1.37% vs 3.38% in Sep 2024

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2024 is 1.92% vs 3.45% in Sep 2024

Interest

QoQ Growth in quarter ended Dec 2024 is 18.60% vs 26.47% in Sep 2024

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2024 has fallen from Sep 2024

Compare Quarterly Results Of Supriya Lifesci. With

Select Peers

Figures in Rs cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

185.65

2,396.57

-2,210.92

-92.25%

Other Operating Income

0.00

Total Operating income

185.65

2,396.57

-2,210.92

-92.25%

Raw Material Cost

13.60

179.72

-166.12

-92.43%

Purchase of Finished goods

0.00

445.60

-445.60

-100.00%

(Increase) / Decrease In Stocks

48.18

34.08

14.10

41.37%

Employee Cost

19.77

521.79

-502.02

-96.21%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

38.15

474.45

-436.30

-91.96%

Total Expenditure (Excl Depreciation)

119.70

1,655.64

-1,535.94

-92.77%

Operating Profit (PBDIT) excl Other Income

65.95

740.93

-674.98

-91.10%

Other Income

2.10

69.82

-67.72

-96.99%

Operating Profit (PBDIT)

68.05

810.75

-742.70

-91.61%

Interest

0.51

199.47

-198.96

-99.74%

Exceptional Items

0.00

Gross Profit (PBDT)

67.54

611.28

-543.74

-88.95%

Depreciation

4.96

87.03

-82.07

-94.30%

Profit Before Tax

62.58

524.25

-461.67

-88.06%

Tax

15.80

107.87

-92.07

-85.35%

Provisions and contingencies

0.00

Profit After Tax

46.78

416.38

-369.60

-88.77%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

46.78

416.38

-369.60

-88.77%

Equity Capital

16.10

40.06

-23.96

-59.81%

Face Value

2.00

1.00

0.00

Reserves

0.00

Earnings per share (EPS)

5.81

10.39

-4.58

-44.08%

Diluted Earnings per share

5.82

10.33

-4.51

-43.66%

Operating Profit Margin (Excl OI)

35.52%

30.92%

0.00

4.60%

Gross Profit Margin

36.38%

25.51%

0.00

10.87%

PAT Margin

25.20%

17.37%

0.00

7.83%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 185.65 Cr

in Dec 2024

Figures in Rs Cr

QoQ Growth in quarter ended Dec 2024 is 11.77% vs 3.41% in Sep 2024

YoY Growth in quarter ended Dec 2024 is 32.54% vs 33.22% in Dec 2023

Quarterly - Standalone Net Profit

Standalone Net Profit 46.78 Cr

in Dec 2024

Figures in Rs Cr

QoQ Growth in quarter ended Dec 2024 is 1.37% vs 3.38% in Sep 2024

YoY Growth in quarter ended Dec 2024 is 57.03% vs 212.92% in Dec 2023

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 65.95 Cr

in Dec 2024

Figures in Rs Cr

QoQ Growth in quarter ended Dec 2024 is 1.92% vs 3.45% in Sep 2024

YoY Growth in quarter ended Dec 2024 is 58.99% vs 195.44% in Dec 2023

Quarterly - Interest

Interest 0.51 Cr

in Dec 2024

Figures in Rs Cr

QoQ Growth in quarter ended Dec 2024 is 18.60% vs 26.47% in Sep 2024

YoY Growth in quarter ended Dec 2024 is 4.08% vs -51.49% in Dec 2023

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 35.52%

in Dec 2024

Figures in Rs %

QoQ Growth in quarter ended Dec 2024 has fallen from Sep 2024

YoY Growth in quarter ended Dec 2024 has improved from Dec 2023